Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  ErbB-2 inhibitor ARRY-380
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Study of ONT-380 vs Placebo in Combo w/ Capecitabine & Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: ONT-380-206, NCI-2016-00402, NCT02614794
Start Over